Service: MEDICINE Allergies: Chief Complaint: Major Surgical or Invasive Procedure: 89 y/o F with h/o dementia, HTN, severe osteopenia s/p recent Films at that time revealed no fracture. Pt was also noted to go per report. EF showed normal ECHO w/ EKG revealing sinus tach. continued and patient was transfered to rehab for PT s/p fall on . pt was much more lethargic than usual. Per her daughter, patient alert and oriented x 2 but had declined since last . 27.5K w/ pyuria and bacturia w/ SBP's in 80s. She received 8L of and initiated on MUST protocol. CXR also revealed evidence of , pt's BP improved and she was weaned off pressors. She was sats remained in the mid-90s. She was then transferred to the Past Medical History: hearing loss mild dementia b/l cataracts surgeries severe osteopenia patient is DNR/DNI. Ok w/ pressors. Daughter (HCP)= Lives at , dtr, involved in care non-contributory Physical Exam: vitals- T 99.8, BP 108/38, HR 106, 100% on NRB orientation heent- PERRLA. no scleral icterus. OP moist. dentures in place CV- RRR. normal S1/S2. no m/r/g EXT- no edema. . O: T 98.1, BP 153/74 (100-150/50-70), HR 106 (90-110s), 95% RA I/O: 960/1.4 yesterday, 530/930 today Gen: NAD, awake Neck: difficult to assess JVD size HEENT: PERRL, EOMI, MMM CV: RR, tachy, no g/m/r Chest: crackles at both bases, left>right Abd: +BS, soft, NT Ext: no edema, 2+ DP Neuro: AO x 2, follows commands ** on transfer to ICU ** Na 143, K 4.1, Cl 100, CO226, BUN 92, Cr 1.7 (b/l=0.6) mag 1.9, phos 2.9 U/A- large blood, mod leuks, WBC CK 73, Trop <0.01 REPORTED BY PHONE TO ,5/30/05,11:05AM. FURTHER IDENTIFICATION TO FOLLOW. SENSITIVITIES: MIC expressed in GRAM NEGATIVE ROD(S) AMPICILLIN------------ S CEFAZOLIN------------- S CEFTRIAXONE----------- S GENTAMICIN------------ S MEROPENEM------------- S TOBRAMYCIN------------ S . Urine cx: ESCHERICHIA COLI. Trimethoprim/sulfa sensitivity confirmed by GRAM POSITIVE BACTERIA. 10,000-100,000 ORGANISMS/ML.. streptococcus or SENSITIVITIES: MIC expressed in ESCHERICHIA COLI AMPICILLIN------------ <=2 S CEFAZOLIN------------- <=4 S CEFTAZIDIME----------- <=1 S CEFUROXIME------------ 4 S IMIPENEM-------------- <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN---------- <=4 S TOBRAMYCIN------------ <=1 S . Portable CXR- ?LLL pneumonia; no SBO, no free air ECHO () EF >55%, E/A 0.5 Brief Hospital Course: fall who p/w urosepsis + LLL pna, enrolled on MUST protocol. 1. Septic Shock: Her sepsis was felt most likely secondary to covered empirically with CTX/Azithro and remained afebrile over on hypoxia, tachycardia, leukocytosis and development of septic developed respiratory distress requiring NRB FM. Therefore to maintain MAP>65. She was able to be weaned off pressors after urine output. Final culture data revealed pan-sensitive E. Coli and azithro were stopped and switched to levaquin. On day prior blood cx from admission. ID was called and, given that the were not added as the gram positive rods were likely a . 2. Altered Mental Status: Her change from baseline was felt non-focal neurologic exam. 3. Hypoxia: Likely secondary to fluid overload in setting of Avoided further IVF's and treated pneumonia with antibiotics as transfusion. She was restarted on her home dose of lasix once . systolic fn. Held anti-hypertensives during hypotensive episode. above, she was restarted on lzasix due to some volume overload. transitioned to PO lasix at discharge. Patient was discharged on . 4. Tachycardia: Pt was noted to have tachycardia while on had sinus tach at 110. She was started on a beta-blocker and in the lateral leads so cardiac enzymes were checked and were . 5. Renal Insufficiency: Cr initially elevated to 1.7. Likely resuccitaion with steady urine output >30cc/hr. 6. Prophylaxis: Bowel Regimen, SC heparin 7. Code: DNR/DNI Medications on Admission: Pravastatin 20mg qday tylenol prn senna famotidine 20mg PO daily vitamin B12 aspirin 325 mg daily Discharge Medications: 1. Pravastatin Sodium 20 mg Tablet Sig: One (1) Tablet PO DAILY 2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 3. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 4. Heparin Sodium (Porcine) 5,000 unit/mL Solution Sig: 5000 5. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) 6. Calcium Carbonate 1,250 mg Tablet Sig: One (1) Tablet PO TID 7. Cyanocobalamin 100 mcg Tablet Sig: One (1) Tablet PO DAILY 8. Famotidine 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 10. Mirtazapine 15 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime). 11. Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day. 12. Levofloxacin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 9 days: last dose on . 13. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID 14. Memantine HCl 5 mg Tablet Sig: One (1) Tablet PO qday (). 15. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day. Extended Care Facility: Primary Diagnoses: 2. Gram negative rod Sepsis 4. Hearing Loss 6. Diastolic CHF, EF 55% Discharge Condition: Please take all medications as prescribed and go to all Provider: , .D. Where: CARDIAC SERVICES Phone: Date/Time: 3:00 You have a follow-up appointment with Dr. on at 3:00pm Completed by:
Date of Birth: Sex: F Service: MEDICINE Allergies: Chief Complaint: none History of Present Illness: 20-25%) who has been having intermittent nausea and vomiting for She was found to have acute renal failure from outpatient visit with urine positive for ketones, anion gap of 18, and blood suggestive of UTI. She had a CXR in the ED which did not show prior to arrival in the ED. In the ED she was started on isulin however she was guiac negative in the ED. Per OMR note patient month and has had weight loss (3lbs). Patient denies any dysuria . the patient was switched to IV ceftriaxone. Patient currently states that she feels well. Denies cp/sob/abd Past Medical History: Hypothyroidism CHF LVEF 20-25% in myocardial infarction in . Eczema Patient lives with her husband and son. Is able to ambulate at non-contributory Physical Exam: Well appearing NAD OP clr. MMM Regular S1,S2. No m/r/g +bs. soft. nt. nd No rashes. CXR: Persistent emphysema. No evidence of acute . CXR: Small left-sided pleural effusion. No consolidation. ECG: Sinus tachycardia. Low limb lead voltage. Left Compared to the previous tracing of the low limb lead . 1:00 pm URINE CULTURE (Final ): PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL Trimethoprim/Sulfa sensitivity testing confirmed by BETA STREPTOCOCCUS GROUP B. 10,000-100,000 SENSITIVITIES: MIC expressed in ESCHERICHIA COLI AMPICILLIN------------ 8 S CEFAZOLIN------------- <=4 S CEFTAZIDIME----------- <=1 S CEFUROXIME------------ 16 I GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN---------- <=4 S TOBRAMYCIN------------ <=1 S 1:00 pm BLOOD CULTURE #1 R AC. ANAEROBIC BOTTLE (Final ): ESCHERICHIA COLI. FINAL SENSITIVITIES. request. SENSITIVITIES: MIC expressed in ESCHERICHIA COLI AMPICILLIN------------ 8 S CEFAZOLIN------------- <=4 S CEFTAZIDIME----------- <=1 S CEFUROXIME------------ 16 I GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S 1:15 pm BLOOD CULTURE ESCHERICHIA COLI. FINAL SENSITIVITIES. request. Trimethoprim/Sulfa sensitivity testing available on SENSITIVITIES: MIC expressed in ESCHERICHIA COLI | | AMPICILLIN/SULBACTAM-- 4 S <=2 S CEFEPIME-------------- <=1 S <=1 S CEFTRIAXONE----------- <=1 S <=1 S CIPROFLOXACIN---------<=0.25 S <=0.25 S IMIPENEM-------------- <=1 S <=1 S PIPERACILLIN---------- <=4 S <=4 S TOBRAMYCIN------------ <=1 S <=1 S ANAEROBIC BOTTLE (Final ): IDENTIFICATION AND SENSITIVITIES PERFORMED FROM AEROBIC 1:57 pm URINE Site: NOT SPECIFIED ESCHERICHIA COLI. IDENTIFICATION AND SENSITIVITIES PERFORMED ON CULTURE # . . 01:00PM URINE Color-Yellow Appear-Hazy Sp -1.010 01:00PM URINE Blood-MOD Nitrite-NEG Protein-NEG 01:00PM URINE RBC-6* WBC-38* Bacteri-FEW Yeast-NONE . 12:45PM URINE Color-Yellow Appear-Clear Sp -1.013 12:45PM URINE Blood-LG Nitrite-NEG Protein-TR 12:45PM URINE RBC-78* WBC-12* Bacteri-NONE Yeast-NONE . 1) DKA: underlying etiology was her UTI and sepsis. With treatment of transitioned to SC insulin once the gap was closed. After this, was increased to 10U daily. With this, BG was improved, though . Pt has a very large leukocytosis on admission which resolved grew pansensitive E.coli. The patient was maintained on IV away and repeat urine was also clear. Given rapid resolution, abx. 3) CARDIOVASCULAR: discharge. Her other outpt regimen was continued with exception may need to be restarted once she is recovered from her acute . Pt's Hct was in mid-high 20s, which is lower than her previous of bleeding. Iron studies were consistent with iron defeciency supplementation. Medications on Admission: Ferrous Sulfate 325mg daily Diovan 80mg daily Lasix 20mg daily Levoxyl 50mcg Toprol XL 25mg daily Discharge Medications: 1. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 2. Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO 3. FOSAMAX 70 mg Tablet Sig: One (1) Tablet PO once a week. 4. Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY 6. Lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 8. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY 9. Insulin Glargine 100 unit/mL Solution Sig: Ten (10) units 10. Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical (2 times a day) as needed for 2 weeks: apply to genital area. Disp:*qs for 2 weeks* Refills:*0* 11. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 7 Disp:*14 Tablet(s)* Refills:*0* Home With Service Facility: diabetic ketoacidosis Discharge Condition: Discharge Instructions: increased to 10units. Continue your prior humalog sliding 2. Follow up as below. pain, pain on urination, BG>400 or consistently over 300. Followup Instructions: 1. Provider: , MD (PCP) Phone: Date/Time: 8:30
Service: MED Allergies: Chief Complaint: nasogastric tube placement History of Present Illness: significant for breast cancer, dementia (unknown etiology), congestive heart failure who presented on with nausea, home. In the ED, she had a fever to 104.8, blood pressure 63/37, protocol. For hemodynamic instability, the patient was time (levophed until , Dobutamine until , and Xigres to hiatal hernia. She was found to have sepsis from a urinary positive for E.coli. She was started on IV ceftriaxone in the the Sinemet for her Parkinson's while in the MICU and was Past Medical History: breast cancer dementia Lives at nursing home. Grandson and daughter Non contributory Physical Exam: Tc 97.8 Tm 98.3 HR 60 O2 100% RA GEN: NAD, awake, oriented to self. clear Lungs clear to auscultation bilaterally murmurs, rubs, or gallops. masses. Ext: Right upper extremity edematous. Bilateral lower extremity Neuro: alert, oriented to self, seldomly moves extremitie, answers "I don't know" to questions, + cogwheel rigidity in the Pertinent Results: 06:25AM BLOOD WBC-7.0 RBC-3.63* Hgb-10.2* Hct-32.0* 06:25AM BLOOD Glucose-81 UreaN-9 Creat-0.5 Na-142 K-3.9 Cl-104 HCO3-28 AnGap-1409/06/04 10:52AM BLOOD Calcium-8.8 08:32PM URINE Color-Yellow Appear-Clear Sp -1.015 Urobiln-NEG pH-5.0 Leuks-SM RBC-5* WBC-6* Bacteri-FEW 8:32 pm URINE CULTURE (Final ): NO GROWTH. ESCHERICHIA COLI. 10,000-100,000 ORGANISMS/ML.. IDENTIFY FURTHER. AMPICILLIN/SULBACTAM-- <=2 S CEFEPIME-------------- <=1 S CEFTRIAXONE----------- <=1 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN---------- <=4 S TOBRAMYCIN------------ <=1 S 1:00 pm BLOOD CULTURE AEROBIC BOTTLE (Final ): NO GROWTH. ANAEROBIC BOTTLE (Final ): NO GROWTH. 3:58 pm BLOOD CULTURE ESCHERICHIA COLI. AMPICILLIN/SULBACTAM-- <=2 S CEFEPIME-------------- <=1 S CEFTRIAXONE----------- <=1 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TRIMETHOPRIM/SULFA---- <=1 S ESCHERICHIA COLI (sensitivities from aerobic bottle). AMPICILLIN------------ =>32 R CEFAZOLIN------------- <=4 S CEFTAZIDIME----------- <=1 S CEFUROXIME------------ <=1 S LEVOFLOXACIN---------- 1 S PIPERACILLIN---------- <=4 S TOBRAMYCIN------------ 2 S Head CT w/o contrast: No evidence of acute intracranial diffusion weighted imaging would be more sensitive in evaluating Right Upper Extremity Venous Doppler U/S: No right upper The left atrium is dilated. There is mild symmetric left hypertrophy. The left ventricular cavity size is normal. Due to technical quality, a focal wall motion abnormality cannot be Overall left ventricular systolic function is normal (LVEF>50%). ventricular chamber size and free wall motion are normal. The leaflets (3) are mildly thickened but not stenotic. The mitral are mildly thickened. There is no mitral valve prolapse. Mild to (+) mitral regurgitation is seen. The tricuspid valve thickened. Moderate tricuspid regurgitation is seen. The regurgitation jet is eccentric and may be underestimated. There sized pericardial effusion. There are no echocardiographic signs No right atrial diastolic collapse is seen. Compared with the Abdominal CT W/WO contrast: 1) Large pericardial Brief Hospital Course: Parkinson's disease and associated dementia, also CHF, breast was treated for urosepsis. She has history of dysphagia and nursing home and had worsened dysphagia this admission with have improved over the hospital course as the patient's Parkinson's disease. At discharge, she has no signs or symptoms swallowing ability of nectar thickened liquids is intact. Aspiration Pneumonia: The patient developed a low grade aspiration pneumonia in setting of tube feedings. The patient has one day left on a course of flagyl 250mg daily. Aspiration prevent future aspiration. The head of the bed should remain swallowing function is compromised, she is at risk for repeat Urosepsis: Urine and blood cultures 8/23 were positive for ampicillin. The patient completed a two week course of IV subsequently been negative. Avoiding Foley catheter use is infection. Decreased Mental Status: In general, the patient's mental status improved at discharge. Reasons for the temporary decreased Parkinson's disease that was briefly untreatable while in the appears to be at baseline mental status, speaking and eating as nursing home. Neurology service was consulted to aid in this evidence on CT scan. Carotid U/S showed mild stenosis less than Parkinson's and was started on enteric coated aspirin 81mg with Parkinson's Disease: This is likely a major contributor to mouths a long time before swallowing. Per neurology consult decreased to 25/100mg orally TID (rather than QID which she was in the upper extremitis more than the lower extremitis and Dysphagia: Contributors include dementia, h/o infection, and was passed for nectar thickened liquids, which is what she was the swallow study was failed. She has tolerated nectar thickened removed. Use of Free Water Protocol was recommended and important. Congestive Heart Failure: While there was no clear history of chest xray and had episodes of increased work of breathing lasix. Her home dose of oral lasix was continued whild following H/O Atrial fibrillation: At discharge the patient is in normal fibrillation in the ICU most likely secondary to urosepsis that no thrombus or vegetations. For DVT prophylaxis, use of values. She is afebrile and continues to be alert, responding you?" "What's your name?"). She continues to do well with patient's grandson and daughter were updated in person or by ranitidine ditropan multivitamin dulcolax tamoxifen diltiazem lactulose 1. Insulin Regular Human 100 unit/mL Solution Sig: per sliding 2. Albuterol Sulfate 0.083 % Solution Sig: One (1) Inhalation 3. Ipratropium Bromide 0.02 % Solution Sig: One (1) Inhalation 4. Heparin Sodium (Porcine) 5,000 unit/mL Solution Sig: One (1) 5. Acetaminophen 160 mg/5 mL Elixir Sig: 650mg PO Q4-6H (every 6. Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID 7. Lactulose 10 g/15 mL Syrup Sig: Thirty (30) ML PO Q8H (every 8. Senna 8.8 mg/5 mL Syrup Sig: One (1) Tablet PO BID (2 times a 9. Docusate Sodium 150 mg/15 mL Liquid Sig: One (1) PO BID (2 10. Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO 11. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) Delayed Release (E.C.)(s) 12. Furosemide 20 mg Tablet Sig: One (1) Tablet PO QD (once a 13. Flagyl 250 mg Tablet Sig: One (1) Tablet PO once a day for 1 14. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO once a day. 16. Iron Oral 17. Ditropan XL 5 mg Tab, Sust Release Osmotic Push Sig: One (1) 18. Actonel 30 mg Tablet Sig: One (1) Tablet PO once a week. 20. Dulcolax Oral 22. Tamoxifen Citrate 10 mg Tablet Sig: One (1) Tablet PO twice Discharge Disposition: - Discharge Diagnosis: urinary tract infection breast cancer dementia Discharge Condition: Please take all medicines as prescribed. Followup Instructions:
Service: MEDICINE Allergies: Chief Complaint: Intubation PEG tube placement Arterial lines PICC placement History of Present Illness: week ago, then developed a nonproductive cough and some and she was placed on Bactrim. Sputum cx was + for MRSA. She supplmental O2 and so was transferred to for further * vanc/levo/flagyl (given possibility of nosocomial infxn). Her team felt she was dry. Later that night, on the floor, she respiratory distress. Her oxygen saturation decreased from 94% 100 cc UOP. CAD s/p bare metal stent to OM1 cholecystitis h/o CVA CRI AF htn s/p PEG tube placement feeds d/c s/p bilateral thoracentesis necrotic right foot R foot dry gangrene s/p AKA Lives with son (healthcare proxy) in , but has been in Family History: T: 99.6 P: 66 BP: 180/63 R: 20 O2 sat 96% on 10L Gen: elderly female, in mod resp distress, alert and oriented Neck: JVD to angle of jaw at 75 degrees Lungs: using accessory muscles, decreased breath sounds R>L ( CV: irreg irreg, no m/r/g Abd: mildly distended, nontender, +bs. Ext: s/p R AKA, no edema on left, warm and well-perfused. 2+ Pertinent Results: Mild biatrial enlargement. Concentric LV hypertrophy. LVEF 50% study in . Pulmonary pressures have increased to 50-55 . . 07:37AM PT-13.8* PTT-28.7 INR(PT)-1.3 07:37AM WBC-8.5 RBC-3.02* HGB-9.2* HCT-27.3* MCV-91 07:37AM MAGNESIUM-2.7* 07:37AM ALT(SGPT)-12 AST(SGOT)-20 LD(LDH)-176 ALK 07:37AM GLUCOSE-133* UREA N-83* CREAT-3.4*# GAP-24* 08:07AM LACTATE-2.4* K+-6.1* 12:05PM proBNP-* 07:33PM TYPE-ART PO2-74* PCO2-44 PH-7.31* TOTAL 11:18PM LACTATE-3.4* Pro BNP , Cardiac Enzymes: Troponin: .08 CK-MB: 4 ECG : rate 63, afib, nl axis, nl intervals, TWI in 1 . CHEST (PORTABLE AP) heart failure. RENAL U.S. . The findings of unilateral small kidney with abnormal waveforms left kidney appears essentially normal. ABDOMINAL A-GRAM There was high-grade ostial stenosis of the left renal artery stenosis of the right renal artery approximately 2 cm from the delineated. Right kidney was reduced in size. Left kidney arteriogram was not performed. CT HEAD W/O CONTRAST lobe Microbiology: STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL {YEAST} INPATIENT | CEFTAZIDIME----------- =>64 R CIPROFLOXACIN--------- =>4 R IMIPENEM-------------- <=1 S MEROPENEM-------------<=0.25 S TOBRAMYCIN------------ <=1 S SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL STAPH AUREUS COAG + CLINDAMYCIN----------- =>8 R GENTAMICIN------------ <=0.5 S OXACILLIN------------- =>4 R RIFAMPIN-------------- <=0.5 S VANCOMYCIN------------ <=1 S BLOOD CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC ENTEROCOCCUS FAECALIS AMPICILLIN------------ <=2 S LEVOFLOXACIN---------- =>8 R PENICILLIN------------ 4 S . BOTTLE-FINAL INPATIENT {STAPH AUREUS COAG +, YEAST} INPATIENT {STAPH AUREUS COAG +} INPATIENT | ERYTHROMYCIN---------- =>8 R LEVOFLOXACIN---------- =>8 R PENICILLIN------------ =>0.5 R TETRACYCLINE---------- <=1 S . INPATIENT ISOLATE} INPATIENT | CHLORAMPHENICOL------- 32 R LINEZOLID------------- 1 S VANCOMYCIN------------ =>32 R 11:12 am BRONCHOALVEOLAR LAVAGE 3+ (5-10 per 1000X FIELD): POLYMORPHONUCLEAR NO MICROORGANISMS SEEN. RESPIRATORY CULTURE (Final ): ENTEROBACTER CLOACAE. 10,000-100,000 ORGANISMS/ML.. GRAM NEGATIVE ROD #2. ~/ML. potential ENTEROBACTER CLOACAE CEFEPIME-------------- <=1 S CEFTRIAXONE----------- =>64 R GENTAMICIN------------ <=1 S LEVOFLOXACIN---------- =>8 R PIPERACILLIN---------- =>128 R . . CBC: 8.9 > 8.3/27.0 < 240 Chem 7: --------------------< 97 . Ca: 8.2 Mg: 2.3 P: 3.1 PT: 20.2 PTT: 37.1 INR: 2.9 #. Respiratory Distress distress with accessory muscle use, tachypnea, and audible not initially clear although thought most likely to represent edeam and recent cessation of cardiac meds on admission. It was film performed at her nursing facility which revealed bibasilar Failing Bactrim therapy the patient was transferred to and for potential nosocomial pneumonia. Upon transfer to the MICU, NH, the patient's therapy was tailored to Vancomycin only, dosed if the patient spikes a new temp, develops new consolidation or not been obtained to date as the patient has not been able to has developed a leukocytosis since admission, as high as 19.3 cardiac disease the patient is known by recent echocardiography with moderate diastolic dysfunction and possible restrictive and Hydralazine for preload and afterload reduction as well as continued to be held as it is the most likely contributing isordil, Hydralazine and metoprolol for additional rate control of CAD with intentions to maximize beta blockade and titrating patient has been undergoing diuresis as well with net negative additionally on transfer was noted to have bilateral pleural decompensated CHF. Given the size of the effusion and the made to perform a right thoracentesis to drain the effusion and The patient underwent a successful thoracentesis with drainage effusion to be non-purulent, therefore less concerning for a the effusion was > 3 and therefore possible consistent with an that the effusion was more likely a pseudoexudate in the setting patient initially had decreased\oxygen requirements titrating requiring non-invasive ventilation during her admission. Given floor but returned to the MICU shortly for repeat hypoxia, non-invasive mask ventilation with bi-PAP. The patient was status, although she did not significantly improve. The patient Given this, facial skin brakedown from the bi-PAP mask and semi-electively intubated. The patient then underwent repeat transudate. tracheostomy tube placed on . She was repeatedly weaned returned to prior levels secondary to tachypnea. She had the transudate. Her vent settings at discharge were PS 10, PEEP 5 * afib with history of junctional arrythymias. On admission to the admission to the MICU the patient developed an atrial arrythymia pauses and junctional escape beats. The patient developed this it is unknown if there is any relationship between the The patient was noted to have associated hypertension rather develop any respiratory decompensation. The patient was given junctional escape, although pauses were less than 3 seconds and that there was no indication for pacing currently, but titration of other meds for blood pressure control after beta on metoprolol 25mg po bid with plans to tirate up as tolerated improved blood pressure control. EP remarked that there was no pulmonary status improved, it would be expected that her atrial that anticoagulation should be considered given her atrial but whether or not to anticoagulate indefinitely will need to be noted to have occasional bradycardia with some pauses and cardiac regimen with regards to her arryhtmyia as well as 6.25mg mg PO q8hr for rate control as well as hydralazine PO and drip for preload reduction with intention to transition back to She had intermittant episodes of atrial fibrillation, often IV lopressor. Additionally, she had episodes of hemodynamically stable. She was put back on metoprolol 12.5mg . #. Hypertension: The patient's outpatient regimen for BP control described above, the patient's losartan has been held in the metoprolol, isordil and hydralazine for the indications above. many agents as well as potential ARF in setting of Losartan it driving her hypertension. Indeed the patient had a renal stenosis. The patient underwent angiography by IR which with normal perfusion and moderate stenosis of the right renal with flow studies indicative of significant stenosis. Because likely secondary to episodes of moderate hypotension as well as to maintain relative hypertension with systolics in the 140 to with hydralyzine and isordil at discharge. #. ARF: On admission the patient was noted to have a Creatinine 1.2 in ). Over the course of her MICU stay the and allowing higher perfusion pressures. All medications have that was bland and not consistent with infection. The patient her creatinine continues to decrease even in the setting of Her renal function improved over the stay, with good urine Stenosis which was too diffuse to intervene. Creatinine * #. CAD: The patient has known CAD with bare metal stent troponin of .08, but a normal CK-MB which likely represented The patient was continued on her outpatient regimen of was not additionally on aspirin and team was told because of given more frequently given her history of eposodes of severe stenting. #. Hypothyroidism - the patient was continued on her outpatient . to have waxing and mental status and mild paranoia PRN at night with decent effect. The patient has a room with made to orient the patient often to where she is, and treatment may additionally been exacerbating her delerium. Her agitation . # CVA: She was found to have a subacute right occipital infarct, of sedation after her tracheostomy. Sge was started on ASA. # Ventilator Associated PNA: she was treated for MRSA VAP with enterobacter cloacae, see sensitivities in results section. sputum. Not thought to be a true pathogen given negative gram signs/symptoms for pneumonia, would start empiric treatment for . # Enteroccocal Bacteremia: she was treated with ampicillin for encterococcus feacales. # Pancreatic Mass: Seen on CT scans of abdomen on and history of pancreatitis in making pancreatic cyst an outpatient after patient is more stable. # C. Diff: she developed C Diff infection which was treated with currently on Day of PO vancomycin. #. CHF: She has a h/o Diastolic dysfunction. Echo showed with lasix throughout her stay and responded well to 80 mg IV, thirty minutes beforehand. She was discharged on daily laisx should be reevaluated daily as to whether the patient requires . #. Anemia: Work up consistent with ACD and iron deficiency #. Ppx: She was anticoagulated with coumadin, PPI, Bowel regimen * feeds through the PEG. #. Code: Full #. Communication with son (consent . sputum cx - rare growth of GNR, ID and sensitivities and blood cx - NGTD, awaiting final report Medications on Admission: Isordil 40 mg po tid Norvasc 10 mg po daily Levothyroxine 88 mcg po daily Clopidogrel 75 mg po daily Bisacodyl prn Gabapentin 100mg po bid Omeprazole 20 mg po daily 1. Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 2. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 3. Levothyroxine 88 mcg Tablet Sig: One (1) Tablet PO DAILY 4. Lansoprazole 30 mg Susp,Delayed Release for Recon Sig: Thirty 5. Ascorbic Acid 500 mg Tablet Sig: 0.5 Tablet PO BID (2 times a 6. Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY 7. Senna 8.8 mg/5 mL Syrup Sig: Five (5) cc PO BID (2 times a 8. Artificial Tear Ointment 0.1-0.1 % Ointment Sig: One (1) Appl 9. Therapeutic Multivitamin Liquid Sig: Five (5) ML PO DAILY 10. Vancomycin 250 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) for 5 days: Today is day . 11. Docusate Sodium 150 mg/15 mL Liquid Sig: One y 12. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 13. Hydralazine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 14. Isosorbide Dinitrate 10 mg Tablet Sig: One (1) Tablet PO TID 15. Metolazone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): 16. Furosemide 10 mg/mL Solution Sig: Eighty (80) mg Injection DAILY (Daily): After metolazone. 17. Heparin Lock Flush (Porcine) 100 unit/mL Syringe Sig: Two (2) ML Intravenous DAILY (Daily) as needed: 10 ml NS followed Daily and PRN post blood draw + infusion. 18. Warfarin 1 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily): 19. Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO TID (3 times a day): Hold for HR<50. 20. Morphine 2 mg/mL Syringe Sig: 2-4 mg Injection Q1H (every 21. Fluconazole 100 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 4 days: Last day . 22. Ipratropium Bromide 0.02 % Solution Sig: One (1) neb 23. Lantus 100 unit/mL Solution Sig: Five (5) units Subcutaneous 24. Insulin Sliding Scale Q4H Please use Humalog 0-50 mg/dL 4 oz. Juice 121-160 mg/dL 2 Units 201-240 mg/dL 8 Units 281-320 mg/dL 14 Units 361-400 mg/dL 20 Units Discharge Disposition: - Discharge Diagnosis: Hypoxic Respiratory failure s/p tracheostomy Atrial fibrillation Bilateral renal artery stenosis Congestive heart failure Hypothyroidism Clostridium dificile colitis Right occipital subacute CVA Peripheral vascular disease Afebrile, stable on ventilator with tracheostomy. Discharge to acute care vent facility Weigh yourself every morning, MD if weight > 3 lbs. . Followup Instructions: She will require follow up of her INR given coumadin for Afib. diuretics should be reevaluated daily as to need for that day. Follow up results of pending microbiology data (please see end
Date of Birth: Sex: F Service: MEDICINE Allergies: Chief Complaint: none History of Present Illness: fibrillation s/p recent hospitalization for ablation, discharged with chills on the day prior to admission. She says that since expected this was normal after the procedure and Of note, about 1 week PTA she noted severe L groin pain. She pain resolved over a couple of days. About 5 days prior to sensation in her pelvis with urination. The following day she following day she began having chills, and her daughter found hospital. She says that the toilet she has been using was maroon colored, urine color or stool color. She denies burning with urination, frequency or urgency. Denies flank pain beyond her usual over the same time course. Denies orthopnea or LE edema. She with standing, HR 70, 97% RA. She was given 4 L NS, , 1) Atrial fibrillation s/p DCCV , with recurrent 2) Depression: Well controlled on zoloft. removed 5) Hypercholestermia: On Lipitor in the past, but now attempting 6) Osteoporosis: On fosamax. 8) PFO - Echo with PFO, EF > 55% Social History: No history of IVDU or alcohol abuse. Family History: VS: 97.8, 105/59, 69, 16, 97% RA Gen: Slim caucasian female appearing well but anxious, sitting Neck: No JVD. Bandage over R side of neck over central line Cor: RR, normal rate, no m/r/g. Lungs: Rales at bases bilaterally. Abd: NABS, soft, NT/ND. No rebound or guarding. Back: No CVAT. Extr: No c/c/e. Rectal: Guaiac negative per ED. Pertinent Results: Plt Ct-362 08:20PM Neuts-85.8* Lymphs-9.9* Monos-3.7 Eos-0.5 Baso-0.1 Glucose-110* UreaN-18 Creat-0.8 Na-129* K-4.0 Cl-96 Cl-102 HCO3-25 LD(LDH)-283* TotBili-0.5 DirBili-0.3 IndBili-0.2 ALT-105* AST-30 LD(LDH)-198 AlkPhos-266* TotBili-0.4 Albumin-3.0* Calcium-8.3* Phos-2.6* Mg-2.0 Iron-31 BLOOD Cortsol-26.0* Urine: 09:20PM URINE Color-Yellow Appear-Clear Sp -1.011 Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-MOD RBC-* WBC->50 Time Taken Not Noted Log-In Date/Time: 9:20 pm URINE Site: CLEAN CATCH **FINAL REPORT ** URINE CULTURE (Final ): PRESUMPTIVE IDENTIFICATION. . SENSITIVITIES: MIC expressed in ESCHERICHIA COLI AMPICILLIN------------ =>32 R CEFAZOLIN------------- <=4 S CEFTAZIDIME----------- <=1 S CEFUROXIME------------ 4 S IMIPENEM-------------- <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TRIMETHOPRIM/SULFA---- R 10:30 pm BLOOD CULTURE Site: ARM AEROBIC BOTTLE (Final ): ESCHERICHIA COLI. FINAL SENSITIVITIES. SENSITIVITIES: MIC expressed in ESCHERICHIA COLI AMPICILLIN------------ =>32 R CEFAZOLIN------------- <=4 S CEFTAZIDIME----------- <=1 S CEFUROXIME------------ 4 S IMIPENEM-------------- <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S 11:00 pm BLOOD CULTURE Site: ARM AEROBIC BOTTLE (Pending): ANAEROBIC BOTTLE (Pending): 10:00 am BLOOD CULTURE LINE OR SITE NOT NOTED. AEROBIC BOTTLE (Pending): ANAEROBIC BOTTLE (Pending): CXR : CHEST AP: Compared to the earlier exam, there has right atrium. There is no evidence of pneumothorax. There is consistent with worsening pulmonary edema. CXR : IMPRESSION: Mild CHF. New, lobulated appearance of exclude a mass in this region. CT abdomen : IMPRESSION: pyelonephritis. may represent a cyst but is too small to be fully characterized. CXR : FINDINGS: AP single view of the chest obtained with similar study (half hour interval). The central venous line has lower portion of the SVC terminating some 2 cm above the level other chest abnormalities in comparison with the previous study. US: The gallbladder is normal, and there is no texture approximately 3 mm and is within normal limits. There is no fluid in the abdomen. 64 year old female with history of atrial fibrillation s/p returns with fatigue x 3 days, and fever to 102 with chills, scan, hypotension on admission responsive to 4 L IVF, thought to 1) Pyelonephritis: Patient with pyelo by CT scan. Changed to acquisition of pyelo during last admission during which time she and one blood culture showed gram negative rods. Patient 2) Hypotension: Presumed secondary to urosepsis. blood s/p 4 L IVF. Post hydration, patient was euvolemic to encouraged PO intake and patient did not require further IVF. Random cortisol was done and was appropriatly > 25. Patients 3) Anemia: Patient with large hct drop with rehydration, groin instrumentation during a-flutter ablation, could have had groin. More likely bled into L groin though, given intense L UTI). CT was negative for RP bleed. Hemolysis labs negative. that. Patient was also guiac negative through hospital course. Anemia should be followed as outpatient. 4) Atrial fibrillation: s/p ablation. Remained in sinus. hypotension, but restarted on discharge - bp 140 at one point. 5) Depression: Continued zoloft. 6) LFTs: LFTs noted to be elevated on , however patient had normal (see report above). LFTs monitored and were trending Likely this is a result of hypotension on the liver during her Calcium supplement 600mg Flecainide 200mg - last dose Saturday, MVI daily Fosamax once/week 1. Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H (every Disp:*11 Tablet(s)* Refills:*0* 2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 Disp:*60 Capsule(s)* Refills:*2* 3. Sertraline HCl 50 mg Tablet Sig: One (1) Tablet PO DAILY 4. Flecainide Acetate 100 mg Tablet Sig: One (1) Tablet PO Q12H 5. Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 6. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day) as needed: Do not take 7. Pramoxine-Mineral Oil-Zinc 1-12.5 % Ointment Sig: One (1) 8. Atenolol 25 mg Tablet Sig: 0.5 Tablet PO once a day. Home Discharge Diagnosis: Anemia Discharge Condition: dilationLFTs trending down Discharge Instructions: chest pain, chills, shortness of breath, abdominal pain, or infection and check your blood count. Resume all of your previous medications, we did not make any 11 days for your urinary tract/kidney infection. Followup Instructions: infection and low blood count. 2. Provider: , M.D. Where: Phone: Date/Time: 8:30 3. Provider: . Where: NEUROLOGY Phone: Date/Time: 9:30
